Multiple Myeloma—Effect of Induction Therapy on Transplant Outcomes-Reference-Cited by-同舟云学术

Multiple Myeloma—Effect of Induction Therapy on Transplant Outcomes

Published:2021-02 Issue:2 Volume:21 Page:80-90.e5
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kumar Lalit,Gundu Naresh^ORCID,Kancharia Harish,Sahoo Ranjit Kumar,Malik Prabhat Singh,Sharma Atul,Gupta Ritu^ORCID,Sharma Omdutt,Biswas Ahitagni,Kumar Rakesh,Thulkar Sanjay,Mallick Saumyaranjan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference20 articles.

1. Induction therapy for newly diagnosed myeloma;Paul;Am Soc Clin Oncol Educ Book,2019

2. NCCN guidelines insights: multiple myeloma version 3.2018;Kumar;J Nat Comp Cancer Netw,2018

3. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

4. Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study;Rosiñol;Blood,2012

5. Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/GMMG-HD4 trial;Sonneveld;J Clin Oncol,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties;International Journal of Molecular Sciences;2024-05-22

2. Risk stratification in multiple myeloma – A review and update;Annals of the National Academy of Medical Sciences (India);2024-05-02

3. Real-world Outcomes in Newly Diagnosed Multiple Myeloma Based on Interphase Fluorescent In situ Hybridization: A Retrospective Analysis;Apollo Medicine;2024-04-04

4. Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India;Applied Health Economics and Health Policy;2024-03-07

5. Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature;Indian Journal of Cancer;2023-10